Key regulatory changes that occur with common neuroblastoma therapy – National Cancer Institute

National Cancer Institute shared a post on X:

“Investigators at the NCI Center for Cancer Research have mapped key regulatory changes that occur when a common neuroblastoma therapy, retinoic acid, drives tumor cells to develop into neurons, thereby curbing their growth. Learn more.”